Skip to main content

Pritchard and Moore Scholarship

Cancer Research Wales is delighted to launch the Pritchard and Moore Scholarship, which honours the legacies of Dr John Pritchard and Professor John Moore.

Start date

11 Jul 2022

Status

Open

Both Dr Pritchard and Professor Moore enjoyed distinguished careers at Velindre Cancer Centre and had a keen interest in radiotherapy-related research.

Together they supported the academic career development of numerous staff and helped to establish Velindre as a centre of research excellence. They both previously served on the Board of Trustees at Cancer Research Wales, with Professor Moore going on to become President of the charity. 

To honour their legacy, Cancer Research Wales have established the Pritchard and Moore Scholarship, which will support a talented researcher to conduct a novel research project in radiotherapy or its wider field.

Proposals are invited from the following disciplines:

  • Radiomics and Radiogenomics
  • Medical Imaging
  • Molecular Radiotherapy
  • Pre-clinical studies (e.g. Radiobiology, DNA damage sensitisers)
  • Combination therapies involving radiotherapy
  • Treatment Planning and Quality Assurance
  • New technologies

If you are unsure if your proposal fits the scope of the Scholarship, please contact the Head of Research, Dr Lee Campbell, at lee.campbell@cancerresearchwales.org.uk.

The Scholarship is open to all of Wales and will fund a PhD studentship or a Post-Doctoral Fellowship, either full or part time.

How to apply?

If you are interested in applying for the Pritchard and Moore Scholarship, please download the Expression of Interest form below.

Once completed, the form is to be returned to the Head of Research, Dr Lee Campbell, by email at lee.campbell@cancerresearchwales.org.uk.

Key Dates:

Expression of interest deadline

22 August 2022

Invitation to submit full application

9 September 2022

Full application deadline

4 November 2022

Cancer Research Wales retains the right to amend these dates where necessary.